Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |